How Cancer Shaped Justice Ruth Bader Ginsburg ’s Life and Work
The name Ruth Bader Ginsburg became almost synonymous with strength and stamina as she rose to prominence in judicial and feminist circles throughout her long career. Famously nicknamed the Notorious RBG and known for her grueling fitness regimen, the late Supreme Court justice also struggled with cancer and other health issues for the better part of her time on the bench — culminating with her death on Sept. 18 at the age of 87 of complications from metastatic pancreatic cancer. Ginsburg’s health issues became public in 1999, six years after her appointment to the Supreme Court, when she had surgery for early-...
Source: TIME: Health - September 19, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Cancer healthytime remembrance Source Type: news

Immunotherapy improves survival in advanced bladder cancer patients
(Queen Mary University of London) An immunotherapy drug called 'avelumab' has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a phase III clinical trial led by Queen Mary University of London and Barts Cancer Centre, UK. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 18, 2020 Category: International Medicine & Public Health Source Type: news

Prostate cancer symptoms: What’s waking you up in the night? Sign of the deadly disease
PROSTATE cancer develops at the base of the bladder, surrounding the first part of the urethra - the tube that carries urine and semen. Do you find it difficult to sleep throughout the night? Here's a sign linked to the deadly disease. (Source: Daily Express - Health)
Source: Daily Express - Health - September 16, 2020 Category: Consumer Health News Source Type: news

If PPIs Are Onboard, Atezolizumab May Not Work for Bladder Cancer If PPIs Are Onboard, Atezolizumab May Not Work for Bladder Cancer
Your patients with atezolizumab-treated bladder cancer may not benefit if they are on a PPI.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 15, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cigarette smoking associated with worse outcomes for bladder cancer patients after surgery
(University of Southern California - Health Sciences) Study from Keck Medicine of USC links smoking with a higher risk of death and cancer recurrence, and less responsiveness to chemotherapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 15, 2020 Category: Cancer & Oncology Source Type: news

Video: Bladder cancer stages
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - September 15, 2020 Category: Consumer Health News Source Type: news

Cancer Projects to Diversify Genetic Research Receive New Grants
Because much cancer research and clinical trials have been based on white populations, efforts to explore the ways race and ethnicity influence disease are underway. (Source: NYT Health)
Source: NYT Health - September 11, 2020 Category: Consumer Health News Authors: Emma Goldberg Tags: Race and Ethnicity Colon and Colorectal Cancer Pancreatic Cancer Bladder Cancer Breast Cancer Black People Genetics and Heredity Cold Spring Harbor Laboratory Dana-Farber Cancer Institute Memorial Sloan-Kettering Cancer Center Mount Si Source Type: news

Advanced Care at Home means leaving the hospital sooner
For John Jolly, retirement means enjoying time with his wife, gardening and walking 10,000 steps daily. But after chemotherapy to treat bladder cancer in 2018, John has had recurrent kidney issues that sometime require hospitalization. The new Advanced Care at Home program, which is part of the Mayo Clinic Platform, got the 72-year-old former certified [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 10, 2020 Category: Databases & Libraries Source Type: news

DNA-Methylation Test Shows Promise in Bladder Cancer Detection, Monitoring DNA-Methylation Test Shows Promise in Bladder Cancer Detection, Monitoring
An assay using methylation markers may offer an alternative to more costly, invasive methods for bladder cancer detection and surveillance, according to a new study.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - September 8, 2020 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Prostate cancer warning: What colour is your urine? The hidden signs in the toilet
PROSTATE cancer symptoms can be difficult to spot during its early stages, but include passing more urine than normal, feeling like your bladder is never truly empty, and having a burning pain when using the toilet. You could also be at risk of a tumour if your pee changes colour. Do you have blood in your urine? (Source: Daily Express - Health)
Source: Daily Express - Health - September 7, 2020 Category: Consumer Health News Source Type: news

Hair dye and cancer risk: Largest study yet
(Medical University of Vienna) Studies have indicated that people who dye their hair regularly may have a higher risk of cancer, especially bladder cancer and breast cancer. Hair dyes contain certain chemicals that have been held responsible for these relationships. In the largest study to date, which followed 117,200 women from the USA over 36 years, this could not be confirmed. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 3, 2020 Category: Cancer & Oncology Source Type: news

Vessi Medical Reaps $1.7 Million in Funding for Minimally Invasive Bladder Cancer Treatment
MISGAV, Israel, Aug. 31, 2020 -- (Healthcare Sales & Marketing Network) -- Vessi Medical, a portfolio company of The Trendlines Group Ltd. (SGX: 42T) (OTCQX: TRNLY) announced that it secured $1.7 million in funding for its cryoablation solution for superf... Devices, Urology, Oncology, Venture Capital Vessi Medical, cryoablation, cryo-spray ablation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 31, 2020 Category: Pharmaceuticals Source Type: news

International team identifies a new regulatory pathway in bladder cancer
(InSilico Medicine) GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 20, 2020 Category: International Medicine & Public Health Source Type: news

GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma
Disruption of the KEAP1-NRF2 pathway results in the transactivation of NRF2 target genes, consequently inducing cell proliferation and other phenotypic changes in cancer cells. Here, we demonstrated that GULP1 was a KEAP1-binding protein that maintained actin cytoskeleton architecture and helped KEAP1 to sequester NRF2 in the cytoplasm. In urothelial carcinoma of the bladder (UCB), silencing of GULP1 facilitated the nuclear accumulation of NRF2, led to constitutive activation of NRF2 signaling, and conferred resistance to the platinum drug cisplatin. Knockdown of GULP1 in UCB cells promoted tumor cell proliferation in vitr...
Source: Signal Transduction Knowledge Environment - August 18, 2020 Category: Science Authors: Hayashi, M., Guida, E., Inokawa, Y., Goldberg, R., Reis, L. O., Ooki, A., Pilli, M., Sadhukhan, P., Woo, J., Choi, W., Izumchenko, E., Gonzalez, L. M., Marchionni, L., Zhavoronkov, A., Brait, M., Bivalacqua, T., Baras, A., Netto, G. J., Koch, W., Singh, A Tags: STKE Research Articles Source Type: news

Antibiotic overuse reduces bladder cancer survival rates
(Flinders University) The overprescribing of antibiotics is reducing survival rates in patients with urothelial carcinoma and it needs to be stopped to avoid the serious risk posed by resitant bacterial infections, according to a new medical study. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 16, 2020 Category: Cancer & Oncology Source Type: news

Gene Therapy Promising in BCG-Unresponsive Bladder Cancer Gene Therapy Promising in BCG-Unresponsive Bladder Cancer
An investigative intravesical viral gene therapy may offer a bladder-sparing alternative for some patients with high-grade, nonmuscle invasive bladder cancer who have few options, results from a phase 3 study show.Medscape Medical News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - August 6, 2020 Category: Urology & Nephrology Tags: Urology News Source Type: news

Bladder cancer symptoms: The colour urine that could signal cancer - what to look for
BLADDER cancer symptoms can be attributed to a host of less serious conditions but it is still imperative to get them checked out. One symptom is a change in the colour of urine. (Source: Daily Express - Health)
Source: Daily Express - Health - July 29, 2020 Category: Consumer Health News Source Type: news

What Are Some Pediatric Oncological Emergencies?
Discussion Pediatric cancers in the US number about 12,000 per year. After injury, it is the second leading cause of death in children and adolescents. Cancer presentations vary widely, but often begin with non-specific symptoms that continue or progress depending on the location and tumor type. Patients can present with oncological emergencies especially if there are mechanical obstruction such as superior vena cava syndrome or cerebral herniation. More commonly are infections due to immunosuppression. Cancer treatment also causes its own myriad of problems that clinicians need to be aware of to diagnosis and treat, but a...
Source: PediatricEducation.org - July 20, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Roche ’s IPATential150 study evaluating ipatasertib in combination with abiraterone and prednisone/prednisolone met one of its co-primary endpoints
      ·Phase III IPATential150 study evaluating ipatasertib in combination with abiraterone and prednisone/prednisolone compared to current standard-of-care (abiraterone and prednisone/prednisolone alone) plus placebo met its co-primary endpoint of radiographic progression free survival (rPFS) in patients with PTEN loss tumoursBasel, 19 June 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the phase III IPATential150 study met its co-primary endpoint of radiographic progression-free survival (rPFS) in patients with metastatic castration-resistant prostate cancer (mCR...
Source: Roche Media News - June 19, 2020 Category: Pharmaceuticals Source Type: news

FDA Approves Keytruda for Certain Mesothelioma Patients
Patients with pleural mesothelioma cancer may have another treatment option after the U.S. Food and Drug Administration approved the use of pembrolizumab for certain metastatic tumors this week. Pembrolizumab, often known by the brand name Keytruda, is a well-known immunotherapy drug already being used with mixed success for several cancers. This latest FDA approval is for the treatment of adult and pediatric cancers with unresectable disease and high mutational burden that have progressed following prior treatment and have no alternative treatment options. A number of mesothelioma patients already are being treated with p...
Source: Asbestos and Mesothelioma News - June 17, 2020 Category: Environmental Health Authors: Fran Mannino Source Type: news

Combination biomarker predicts response to immune checkpoint therapy in patients with advanced bladder cancer
(University of Texas M. D. Anderson Cancer Center) A combination of two biomarkers was predictive of improved clinical responses and prolonged survival following treatment with immune checkpoint inhibitors in patients with advanced bladder cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 17, 2020 Category: Cancer & Oncology Source Type: news

Upstate physician earns key appointment to North American clinical trials consortium board
Joseph Jacob, MD, MCR, assistant professor of urology and director of the Bladder Cancer Program has been named as member of the board of directors of the Society of Urological Oncology Clinical Trials Consortium (Source: SUNY Upstate Medical)
Source: SUNY Upstate Medical - June 10, 2020 Category: Universities & Medical Training Tags: News Source Type: news

Synthesized cell culture process sets stage for more efficient cancer research
(Tokyo University of Agriculture and Technology) Researchers in Japan have replicated cancer cells from diseased bladder tissue in dogs, minimizing the use of costly stem cell products. The synthesized tumor cells allow scientists to diagnose cancer and optimize treatment without putting the patient through tiresome rigors of chemotherapy trial and error. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 10, 2020 Category: International Medicine & Public Health Source Type: news

What Causes Free Peritoneal Fluid?
Discussion Peritoneal fluid is normal. It decreases the friction of the peritoneum covering abdominal and pelvic organs and helps to protect them and allow their movement. A normal amount of peritoneal fluid is expected on radiological evaluation. Increased peritoneal fluid is a continuum and is concerning as a wide variety of pathological causes are associated with it such as abdominal trauma and appendicitis. At the far end of the scale is ascites that is the accumulation of free fluid more than 25 ml. It is usually associated with abdominal distension but fluid must accumulate before distension can occur and therefore i...
Source: PediatricEducation.org - June 8, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

No Role for Adjv Atezolizumab in Muscle-Invasive Bladder Cancer No Role for Adjv Atezolizumab in Muscle-Invasive Bladder Cancer
Adjuvant atezolizumab failed to improve disease-free survival, and there was no prespecified subgroup, including patients with higher PD-L1 status, that showed treatment benefit.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 4, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Moving on Up: Maintenance Therapy Extends OS in Bladder Cancer Moving on Up: Maintenance Therapy Extends OS in Bladder Cancer
Maintenance immunotherapy after successful chemotherapy for patients with advanced urothelial cancers is a new standard of care, says author.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 28, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Durvalumab Phase III Trial Could Change Mesothelioma Care
An international, much-anticipated phase III clinical trial that could change standard-of-care treatment for patients with malignant pleural mesothelioma will open soon, pending COVID-19 pandemic restrictions. The randomized trial will be studying the effectiveness of the immunotherapy drug durvalumab (Imfinzi) when used in combination with chemotherapy drugs pemetrexed (Alimta) and cisplatin for mesothelioma. Opening dates may vary by center because of the COVID-19 pandemic that has slowed or stalled clinical trials everywhere. Durvalumab produces an antibody that helps a patient’s own immune system kill tumor cell...
Source: Asbestos and Mesothelioma News - May 28, 2020 Category: Environmental Health Authors: Fran Mannino Source Type: news

Immunotherapy improves survival in patients with advanced bladder cancer
(Queen Mary University of London) An immunotherapy drug called 'avelumab' has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a phase III clinical trial led by Queen Mary University of London and Barts Cancer Centre, UK. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 28, 2020 Category: Cancer & Oncology Source Type: news

Onc Daily: COVID-19 Impedes Cancer Trials, Bladder Cancer Study Onc Daily: COVID-19 Impedes Cancer Trials, Bladder Cancer Study
Here are the most important stories that Medscape Oncology's editors picked for you to read today.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 22, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

‘Could It Work as a Cure? Maybe.’ A Herbal Remedy for Coronavirus Is a Hit in Africa, But Experts Have Their Doubts
On April 20, the president calls a press conference to announce a breakthrough in the fight against COVID-19. It’s a new use for an old malaria treatment, he says, one that is seeing miraculous results among the country’s most ill patients. It’s so safe that even schoolchildren could take it. In fact, he urges them to do so daily, as a preventative. He admits that he, too, is taking the medicine. No, this is not the President of the United States touting an unproven remedy for a virus that has infected nearly 5 million people worldwide. It is Madagascar’s President Andry Rajoelina, who is just as wi...
Source: TIME: Health - May 22, 2020 Category: Consumer Health News Authors: Aryn Baker Tags: Uncategorized COVID-19 overnight Source Type: news

' Every Patient Would Applaud' Bladder Cancer Surveillance Study'Every Patient Would Applaud' Bladder Cancer Surveillance Study
High-risk bladder cancer post-surgery follow-up is intensive and based on expert opinion. A new study questions that intensity and opinion.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 22, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Some patients with bladder cancer 'can't wait' for treatment during the COVID-19 pandemic
(IOS Press) Bladder cancer is associated with significant illness and mortality, particularly if treatment is delayed. Writing in the journal Bladder Cancer, researchers have outlined recommendations for treatment of both muscle invasive (MIBC) and non-muscle invasive (NMIBC) bladder cancer during the COVID-19 pandemic based on data from trials and prior studies, and taking into account the current strains on the healthcare system. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 21, 2020 Category: Infectious Diseases Source Type: news

High BMI in Childhood May Up Risk for Bladder Cancer as Adult
Height inversely linked to bladder cancer, while excess BMI gain in childhood linked to increased risk (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 20, 2020 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Internal Medicine, Oncology, Pediatrics, Urology, Journal, Source Type: news

High BMI in Childhood May Up Risk for Bladder Cancer as Adult
WEDNESDAY, May 20, 2020 -- Childhood body mass index (BMI) is positively associated, while childhood height is inversely associated, with the risk for bladder cancer (BC) in adulthood, according to a study published online May 19 in the Annals of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 20, 2020 Category: Pharmaceuticals Source Type: news

Childhood obesity raises bladder cancer risk, study looking at 315,000 children suggests
(Taylor& Francis Group) Adults who were overweight in childhood may be at greater risk of developing bladder cancer, according to new findings published in Annals of Human Biology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 19, 2020 Category: Cancer & Oncology Source Type: news

Drug Combo Offers Hope Against Advanced Bladder Cancer
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 15, 2020 Category: Cancer & Oncology Tags: Oncology, Pharmacy, Research, News, Source Type: news

Drug Combo Offers Hope Against Advanced Bladder Cancer
Title: Drug Combo Offers Hope Against Advanced Bladder CancerCategory: Health NewsCreated: 5/14/2020 12:00:00 AMLast Editorial Review: 5/15/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 15, 2020 Category: Cancer & Oncology Source Type: news

Drug Combo Offers Hope Against Advanced Bladder Cancer
THURSDAY, May 14, 2020 -- A combination of chemotherapy and immunotherapy may slow the progress of metastatic bladder cancer and extend survival, a clinical trial suggests. Current treatment for advanced bladder cancer is chemotherapy, but adding... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 14, 2020 Category: General Medicine Source Type: news

Could BCG, a 100-year-old Vaccine for Tuberculosis, Protect Against Coronavirus?
This article is republished from The Conversation under a Creative Commons license. Read the original article. The post Could BCG, a 100-year-old Vaccine for Tuberculosis, Protect Against Coronavirus? appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - May 14, 2020 Category: International Medicine & Public Health Authors: External Source Tags: Global Headlines Health Source Type: news

Combination of chemo and immunotherapy is shown to work against metastatic bladder cancer
(The Mount Sinai Hospital / Mount Sinai School of Medicine) A clinical trial led by Mount Sinai researchers has showed for the first time that combining chemotherapy and immunotherapy can slow down metastatic bladder cancer. The trial also showed that immunotherapy alone may be an option for a subset of patients with metastatic bladder cancer if their tumor expresses a high level of a protein called PD-L1 according to the study, published in The Lancet in May. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 14, 2020 Category: Cancer & Oncology Source Type: news

Scientists recreate DNA damage caused by toxins from smoking
(University of York) Researchers from the University of York have recreated how toxins from smoking cause unique patterns of DNA damage. The discovery could help scientists better understand the cause of bladder cancer and the link to smoking.The causes of bladder cancer remain largely unknown, however smoking is seen as the main risk factor for the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 28, 2020 Category: Cancer & Oncology Source Type: news

Janssen Announces Submission of Two Applications to U.S. FDA Seeking Approval of SIMPONI ARIA ® (golimumab) for the Treatment of Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis
HORSHAM, PA, April 24, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of two supplemental Biologics License Applications (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of SIMPONI ARIA® (golimumab) for the treatment of polyarticular juvenile idiopathic arthritis (pJIA) and juvenile psoriatic arthritis (jPsA), in patients two years of age and older in combination with methotrexate. If approved for these indications, SIMPONI ARIA would be the first anti-tumor necrosis factor (TNF)-alpha biologic agent administered by intravenous infusion av...
Source: Johnson and Johnson - April 24, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Immunotherapy After Chemo May Slow Metastatic Bladder Cancer Progression Immunotherapy After Chemo May Slow Metastatic Bladder Cancer Progression
In patients with metastatic bladder cancer, progression-free survival was prolonged by switching to pembrolizumab immediately after platinum-based chemotherapy, in a phase-2 trial.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 16, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

New 'toolbox' for urological cancer detection
(University of Turku) Researchers from Ghent University, Belgium, together with researchers from the University of Turku, Finland, have developed a new method for biomarker discovery of urological cancers. The method enables timely diagnosis and treatment of cancer. Urological cancers include e.g. prostate, bladder and kidney cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 16, 2020 Category: Cancer & Oncology Source Type: news

Scientists find that a strain of the common cold virus may REVOLUTIONIZE bladder cancer treatments
(Natural News) Viruses are usually associated with causing disease. However, scientists have long been fascinated by their ability to rewrite a host cell’s DNA, and whether it could be used for good. Now, a recent study suggests that a strain of the virus that causes the common cold may be used to help cure one type of... (Source: NaturalNews.com)
Source: NaturalNews.com - April 12, 2020 Category: Consumer Health News Source Type: news

Immunotherapy treatment after chemotherapy significantly slows metastatic bladder cancer
(The Mount Sinai Hospital / Mount Sinai School of Medicine) Using immunotherapy immediately after chemotherapy treatment in patients with metastatic bladder cancer significantly slowed the progression of the cancer, according to results of a clinical trial led by Mount Sinai researchers published in the Journal of Clinical Oncology in April, 2020. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 9, 2020 Category: Cancer & Oncology Source Type: news

Updated Results for Infigratinib in Metastatic Urothelial Cancer
Researchers reported updated findings of infigratinib in upper tract urothelial carcinoma and urothelial carcinoma of the bladder, supporting the development of phase III studies in this setting. (Source: CancerNetwork)
Source: CancerNetwork - April 2, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

New Florida Legislation Protects Firefighters from Mesothelioma
The Florida Legislature has passed a bill designed to better protect its firefighters from cancer-causing contaminants, including toxic asbestos. By approving the legislation, Florida joined a growing number of states that have passed laws in recent years to help firefighters combat occupational hazards they face every day. The Firefighter Cancer Decontamination Equipment Grant Program in Florida will provide funding for departments to procure supplies, equipment and add additional training that should reduce exposure to hazardous pollutants. It includes all fire departments across the state, from large municipal entities...
Source: Asbestos and Mesothelioma News - March 30, 2020 Category: Environmental Health Authors: Fran Mannino Source Type: news

E-Cigarette Users Have Carcinogen Biomarkers Linked to Bladder Cancer in Their Urine E-Cigarette Users Have Carcinogen Biomarkers Linked to Bladder Cancer in Their Urine
Biomarkers of carcinogens with a strong link to bladder cancer are present in urine of e-cigarette users, a systematic review suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 26, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Biomarkers of Carcinogens Linked to Bladder Cancer in Urine of E-Cigarette Users
Biomarkers of carcinogens, including several with a strong link to bladder cancer, were found to be present in the urine of e-cigarette users. (Source: CancerNetwork)
Source: CancerNetwork - March 25, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news